BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 7682882)

  • 1. Influence of Epstein-Barr virus encoded latent membrane protein 1 on the expression of CD23 antigen, ICAM-1 and LFA-3 in Hodgkin and Reed-Sternberg cells. A morphometric analysis.
    Sandvej KB; Hamilton-Dutoit SJ; Pallesen G
    Leuk Lymphoma; 1993 Jan; 9(1-2):95-101. PubMed ID: 7682882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency.
    Kanavaros P; Jiwa M; van der Valk P; Walboomers J; Horstman A; Meijer CJ
    Hum Pathol; 1993 Jul; 24(7):725-9. PubMed ID: 8100553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of the EBV latent membrane protein (LMP-1) is independent of CD23 and bcl-2 in Reed-Sternberg cells in Hodgkin's disease.
    Armstrong AA; Gallagher A; Krajewski AS; Jones DB; Wilkins BS; Onions DE; Jarrett RF
    Histopathology; 1992 Jul; 21(1):72-3. PubMed ID: 1321789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-expression of Epstein-Barr virus latent membrane protein and vimentin in "aggressive" histological subtypes of Hodgkin's disease.
    Carbone A; Gloghini A; Zanette I; Canal B; Rizzo A; Volpe R
    Virchows Arch A Pathol Anat Histopathol; 1993; 422(1):39-45. PubMed ID: 7679848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical detection of Epstein-Barr virus-encoded latent membrane protein in Reed-Sternberg cells and variants of Hodgkin's disease.
    Pinkus GS; Lones M; Shintaku IP; Said JW
    Mod Pathol; 1994 May; 7(4):454-61. PubMed ID: 7520586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of EBV encoded latent membrane protein 1 (LMP-1) and bcl-2 protein in childhood and adult Hodgkin's disease: application of microwave irradiation for antigen retrieval.
    Kaczorowski S; Kaczorowska M; Christensson B
    Leuk Lymphoma; 1994 Apr; 13(3-4):273-83. PubMed ID: 7914127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.
    Wang F; Gregory C; Sample C; Rowe M; Liebowitz D; Murray R; Rickinson A; Kieff E
    J Virol; 1990 May; 64(5):2309-18. PubMed ID: 2157887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease.
    Pallesen G; Hamilton-Dutoit SJ; Rowe M; Young LS
    Lancet; 1991 Feb; 337(8737):320-2. PubMed ID: 1671232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of the expression of Epstein-Barr virus latent membrane protein and in situ hybridization with biotinylated BamHI-W probes in Hodgkin's disease.
    Delsol G; Brousset P; Chittal S; Rigal-Huguet F
    Am J Pathol; 1992 Feb; 140(2):247-53. PubMed ID: 1310829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient expression of the Epstein-Barr virus LMP1 gene in B-cell chronic lymphocytic leukemia cells, T cells, and hematopoietic cell lines: cell-type-independent-induction of CD23, CD21, and ICAM-1.
    Peng M; Lundgren E
    Leukemia; 1993 Jan; 7(1):104-12. PubMed ID: 8093369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Epstein-Barr virus in Hodgkin-Reed-Sternberg cells : no evidence for the persistence of integrated viral fragments inLatent membrane protein-1 (LMP-1)-negative classical Hodgkin's disease.
    Staratschek-Jox A; Kotkowski S; Belge G; Rüdiger T; Bullerdiek J; Diehl V; Wolf J
    Am J Pathol; 2000 Jan; 156(1):209-16. PubMed ID: 10623669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of c-myc and bcl-2 oncogene products in Reed-Sternberg cells independent of presence of Epstein-Barr virus.
    Jiwa NM; Kanavaros P; van der Valk P; Walboomers JM; Horstman A; Vos W; Mullink H; Meijer CJ
    J Clin Pathol; 1993 Mar; 46(3):211-7. PubMed ID: 8385158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased expression of cellular markers in Epstein-Barr virus-positive Hodgkin's disease.
    Bai MC; Jiwa NM; Horstman A; Vos W; Kluin PH; Van der Valk P; Mullink H; Walboomers JM; Meijer CJ
    J Pathol; 1994 Sep; 174(1):49-55. PubMed ID: 7525910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of follicular dendritic reticulum cells to Reed-Sternberg cells of Hodgkin's disease with emphasis on the expression of CD21 antigen.
    Delsol G; Meggetto F; Brousset P; Cohen-Knafo E; al Saati T; Rochaix P; Gorguet B; Rubin B; Voigt JJ; Chittal S
    Am J Pathol; 1993 Jun; 142(6):1729-38. PubMed ID: 7685151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between Epstein-Barr virus and Chinese Hodgkin's disease.
    Zhou XG; Hamilton-Dutoit SJ; Yan QH; Pallesen G
    Int J Cancer; 1993 Sep; 55(3):359-63. PubMed ID: 8397160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral latent membrane protein 1 (LMP-1)-induced CD99 down-regulation in B cells leads to the generation of cells with Hodgkin's and Reed-Sternberg phenotype.
    Kim SH; Shin YK; Lee IS; Bae YM; Sohn HW; Suh YH; Ree HJ; Rowe M; Park SH
    Blood; 2000 Jan; 95(1):294-300. PubMed ID: 10607715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of the detection of Epstein-Barr virus DNA in lymph nodes in patients with Hodgkin's disease.
    Knecht H; Joske DJ; Bachmann E; Sahli R; Odermatt BF
    Leuk Lymphoma; 1992 Nov; 8(4-5):319-25. PubMed ID: 1337849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle.
    Vockerodt M; Wei W; Nagy E; Prouzova Z; Schrader A; Kube D; Rowe M; Woodman CB; Murray PG
    J Pathol; 2013 Aug; 230(4):399-409. PubMed ID: 23592216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution and phenotype of Epstein-Barr virus-harboring cells in Hodgkin's disease.
    Herbst H; Steinbrecher E; Niedobitek G; Young LS; Brooks L; Müller-Lantzsch N; Stein H
    Blood; 1992 Jul; 80(2):484-91. PubMed ID: 1320954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variable expression of Epstein-Barr virus latent membrane protein I in Reed-Sternberg cells of Hodgkin's disease.
    Teramoto N; Cao L; Kawasaki N; Tonoyama Y; Sarker AB; Yoshino T; Takahashi K; Akagi T
    Acta Med Okayama; 1996 Oct; 50(5):267-70. PubMed ID: 8914680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.